The shortcut isn't a pill. It's the right pill, prescribed correctly.

Semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) are the two FDA-approved GLP-1 medications driving the weight-loss revolution. The right one for you depends on your starting weight, your metabolic markers, your tolerance profile, and your goals — not a one-size-fits-all algorithm.

Your telemedicine consult covers candidacy for both. The physician reviews your situation, contraindications, and goals, then writes for whichever GLP-1 fits. Most patients lose 15–22% of body weight on tirzepatide over a year; semaglutide trends slightly lower but with a smoother side-effect curve for some. We help you pick correctly the first time.

$99 — telemedicine consult. No lab work required. Medication is billed separately after the physician writes your script.

After payment, our care coordinator will email you within 24 hours to schedule your telemedicine consult with the appropriate physician in our network.

Medical Disclaimer: My4MLife provides access to telehealth services and prescription medications through licensed healthcare providers and pharmacies. Compounded medications are not FDA-approved. Individual results may vary. GLP-1 medications are prescription-only and require a physician evaluation. This website does not provide medical advice. Always consult with a qualified healthcare provider regarding your health. Testimonials reflect individual experiences and are not guarantees of results. Images may use models for privacy.